Engineering Health Access

Event Date: April 14, 2021
Time: 3:30-5 p.m. EDT
Priority: No
School or Program: Biomedical Engineering
College Calendar: Show

Abstract

The pandemic birthed unprecedented innovations in diagnostic technologies and decentralized their implementation for COVID-19 detection and surveillance. Drawing from examples of innovation in the current pandemic, experts will discuss challenges in developing and implementing solutions designed to increase health access as well as lessons learned and advice for carrying these opportunities forward in the post-COVID pandemic future.

What advances made these innovations possible? How can future innovations leverage these changes to reach populations with limited health care access? How can we design engineering solutions to reach underserved patients from the start? Where are new opportunities?

Bios

Jacqueline Linnes

Moderator

Jacqueline LinnesJacqueline Linnes is the Marta E. Gross Assistant Professor of Biomedical Engineering at Purdue University. Her work emphasizes the application of fundamental microfluidic principles and biological assays to develop point-of-care diagnostics and wearable devices for low-resource settings in the United States and globally. Research in the lab focuses on advances in paper microfluidics, molecular biosensors, and human-centered instrumentation design to enable sensitive, robust, and rapid diagnostics for informed health care decision-making. Dr. Linnes’ extensive experience in translational research includes co-founding and managing early-stage user feedback for three start-up companies and leading health-related quality of life assessments with Engineers Without Borders in rural Bolivia. She has co-developed mobile diagnostics, wearable devices, airborne pathogen inactivation tools, and water purification technologies with users in the United States, Nicaragua, Kenya, Zambia, and Haiti. She applies these experiences in her teaching of undergraduate engineering Capstone Design courses, graduate level point-of-care diagnostics, and international workshops on human-centered design and medical device translation.


Zachary Hass

Panelist

Zachary HassZachary Hass is currently an assistant professor with a joint appointment in the Schools of Nursing and Industrial Engineering at Purdue University and a core faculty member of the Regenstrief Center for Healthcare Engineering. Equipped with a PhD in statistics and post-doctoral training in health services research, his research program focuses on evaluating policies, programs, and interventions that impact health systems that serve vulnerable and older adult populations. Examples include long-term care, home and community based services, adult protective services, and rural health.


Sanjay Malkani

Panelist

Sanjay MalkaniSanjay Malkani is a founder and Director of GenePace Laboratories in Indianapolis, a high-throughput molecular testing company. He is also a Director of Omega Laboratories, an esoteric clinical lab operating in the US and Canada, and a Director of Versea Holdings, Inc, a bioscience company in the Dx and Rx space. As a consultant, he supports major PE firms with diligence and diagnostic asset board engagements.

For the decade ending Q118, Sanjay served as Global President of the Toxicology division of Alere, Inc (NYSE: ALR), the Global leader in diversified toxicology products, services and rapid diagnostics. Sanjay was a platform consolidator and grew the business from ~$50MM to ~$650MM, deploying ~$1.1B into over 30 merged assets to form a stand-alone division of 2,500+ employees across all major world regions, delivering on significant value creation as measured by a leading Global strategy and Board advisory firm.

As a named executive officer and member of the companys executive team, he supported Aleres $5.3 billion sale to Abbott Laboratories, Inc (NYSE: ABT) in 2017.

Sanjay has executive experience across diversified In-Vitro Diagnostics platforms - including Biologics, Point-of-Care Diagnostics, Laboratory Services and Health Information Solutions - and has developed the world-leading business in every healthcare category he has worked in. He held successive executive and commercial leadership positions within the Point-of-Care and Diabetes Care divisions of Roche Diagnostics, Inc. from 2001 to 2008, and within the Specialty Chemicals division of Dow Chemical, Inc.

Sanjay holds an MBA from the Kellogg School at Northwestern University (1998) and an undergraduate degree in Industrial Engineering from Purdue University (1991).


Natalia Rodriguez

Panelist

Natalia RodriguezNatalia Rodriguez is an assistant professor in the Department of Public Health at Purdue University, with a courtesy appointment in the Weldon School of Biomedical Engineering. Her interdisciplinary translational research program lies at the intersection of public health and biomedical engineering, and centers on the design of health technologies and tailored implementation strategies to address health disparities in underserved communities. She employs community-based participatory approaches to understand multilevel determinants of health and improve upon mechanisms for uptake and adoption of innovative technologies to empower community health workforces, strengthen health systems, and improve health outcomes for vulnerable populations.


Sarah Wiehe

Panelist

Sarah Wiehe Sarah Wiehe, MD, MPH, is co-director of the Indiana Clinical and Translational Sciences Institute and its Community Health Partnerships program, Patient Engagement Core, and the Monon Collaborative initiative. She is a pediatrician and public health researcher.

Dr. Wiehe is an investigator at the Regenstrief Institute and serves as division chief of Children’s Health Services Research in Pediatrics and associate dean of Community and Translational Research at Indiana University School of Medicine as well as adjunct faculty of Geography at the School of Liberal Arts and Epidemiology at the Richard M. Fairbanks School of Public Health at IUPUI.

Dr. Wiehe’s research focuses on health equity issues among children, adolescents, and young adults. Specifically, she engages community stakeholders and leverages existing data to identify mechanisms and opportunities for intervention in order to improve health among vulnerable populations. She partners with patients and community stakeholders to strengthen the relevance, the impact and the sustainability to her work.